CHICAGO--(BUSINESS WIRE)--Fitch Ratings has assigned a 'BBB+' rating to the $1.5 billion bond issuance by Cardinal Health, Inc. (Cardinal; NYSE: CAH). Proceeds are expected to be used to help fund recently announced acquisitions, including the $1.9 billion acquisition of Cordis from Johnson & Johnson (NYSE: JNJ) and the $1.1 billion purchase of the Harvard Drug Group (Harvard). Cash on hand will fund the remainder of the acquisition costs. Cardinal's acquisition of Harvard has strong strate
| < Prev | Next > |
|---|
